FNB in Meniscal Tear Under GA
Launched by CHUNCHEON SACRED HEART HOSPITAL · Sep 19, 2023
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a method called a femoral nerve block, which is used to help manage pain during arthroscopic surgery for meniscus tears. The researchers want to see how effective this pain management technique is when combined with general anesthesia, which means you would be fully asleep during the surgery. The trial is not yet recruiting participants, but it will include men and women aged 18 to 65 who are scheduled for meniscus surgery and are willing to learn more about the study and give their consent to join.
To be eligible for this trial, participants should not have other knee injuries that need surgery at the same time, and they should not have had previous surgeries on their knee. They also need to be in good health without any complications that could affect the surgery. If you decide to participate, you can expect to receive detailed information about the study before making your decision. This research aims to improve pain management during knee surgeries, which could lead to better recovery experiences for patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - individuals who are scheduled to undergo meniscal surgery and must be received sufficient explanation about the research prior to surgery and have provided their informed consent to participate.
- Exclusion Criteria:
- • who require simultaneous surgery for concomitant cartilage injury, collateral ligament tear.
- • who have previously undergone surgical treatment within the knee joint.
- • who have declined to participate in the research.
- • where medical, surgical, or anesthetic complications occurred during surgery.
- • other cases deemed necessary by the researchers.
About Chuncheon Sacred Heart Hospital
Chuncheon Sacred Heart Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Located in Chuncheon, South Korea, the hospital is committed to delivering high-quality care while fostering a collaborative environment for researchers and healthcare professionals. With a focus on various therapeutic areas, Chuncheon Sacred Heart Hospital leverages its state-of-the-art facilities and experienced clinical teams to conduct rigorous trials that adhere to the highest ethical standards. The institution aims to enhance medical knowledge and contribute to the development of new treatments that address unmet patient needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chuncheon, Gangwon Do, Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported